期刊文献+

肠道屏障与肠道菌群在溃疡性结肠炎中的研究进展 被引量:3

Research progress of intestinal barrier and gut microbiota in ulcerative colitis
原文传递
导出
摘要 溃疡性结肠炎(ulcerative colitis,UC)是一种发病机制不明的炎症性肠道疾病,发病率不断上升。完整的肠道屏障对维持肠道稳态和防治疾病至关重要。肠道菌群在构成肠道屏障、增强肠黏膜免疫反应和维持肠道内环境方面具有重要作用。肠道内菌群失衡会导致肠道屏障损伤,而肠道屏障损伤和肠道菌群失衡参与UC的发生发展。近年来,关于UC的研究越来越多地从肠道屏障和调节肠道菌群方面进行。本文就肠道屏障的组成及肠道菌群在UC中的作用进行综述,为该领域今后的研究提供理论依据。 Ulcerative colitis(UC)is an inflammatory bowel disease with unknown pathogenesis and increasing incidence.An intact intestinal barrier is essential for maintaining intestinal homeostasis and preventing diseases.The gut microbiota plays a crucial role in constituting the intestinal barrier,enhancing the immune response of the intestinal mucosa,and maintaining the intestinal environment.The gut microbiota imbalance can lead to intestinal barrier damage,and both intestinal barrier damage and gut microbiota imbalance are involved in the development of UC.In recent years,increasing studies of UC focused on the intestinal barrier and regulation of gut microbiota have been carried out.This article reviews the components of the intestinal barrier and the role of gut microbiota in UC,aiming to provide a theoretical basis for the future research in this field.
作者 叶梦玲 刘阳 汤磊磊 蒋国军 YE Mengling;LIU Yang;TANG Leilei;JIANG Guojun(School of Pharmacy,Hangzhou Normal University,Hangzhou 311121,Zhejiang,China;Department of Pharmacy,Affiliated Xiaoshan Hospital,Hangzhou Normal University,Hangzhou 311200,Zhejiang,China)
出处 《微生物学通报》 CAS CSCD 北大核心 2024年第9期3384-3397,共14页 Microbiology China
基金 杭州生物医药和健康产业发展扶持科技专项(2022WJC139)。
关键词 溃疡性结肠炎 肠道屏障 肠道菌群 微生态制剂 ulcerative colitis intestinal barrier gut microbiota microecological preparation
  • 相关文献

参考文献8

二级参考文献42

  • 1刘太明,蒋学华.黄芩苷和黄芩素大鼠在体胃、肠的吸收动力学研究[J].中国中药杂志,2006,31(12):999-1001. 被引量:79
  • 2Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications [ J ]. Nat Rev Gastroenterol Hepatol,2012,9 (2) :88-96.
  • 3Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriothera- py) for recurrent Clostridium difficile infection [ J]. Clin Infect Dis,2011,53(10) :994-1002.
  • 4EISEMAN B, SILEN W, BASCOM GS, et al. Fecal ene- ma as an adjunct in the treatment of pseudomembranous enterocolitis [ J ]. Surgery, 1958,44 ( 5 ) :854-859.
  • 5Bowden TA Jr, Mansberger AR Jr, Lykins LE. Pseud- omembraneous enterocolitis: mechanism for restoring rio- ral homeostasis [ J ]. Am Surg, 1981,47 (4) : 178-183.
  • 6Freeman J, Bauer MP, Baines SD, et al. The changing epidemiology of Clostridium difficile infections [ J ]. Clin Microbiol Rev,2010,23 (3) :529-549.
  • 7Kelly CP, LaMont JT. Clostridium difficile--more diffi- cult than ever [J]. N Engl J Med,2008,359(18) :1932 - 1940.
  • 8Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora [ J ]. Lancet, 1989,1 (8630) :164.
  • 9Borody TJ, George L, Andrews P, et al. Bowel-flora altera- tion: a potential cure for inflammatory bowel disease and irritable bowel syndrome [ J ]. Med J Aust, 1989, 150 (10) :604.
  • 10Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube [J]. Clin Infect Dis ,2003,36(5 ) :580-585.

共引文献256

同被引文献18

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部